Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GSK to withdraw Blenrep’s U.S. marketing authorization after FDA request By: MarketWatch November 22, 2022 at 03:42 AM EST The pharmaceutical giant said the request comes after its Dreamm-3 Phase 3 study didn't meet its primary endpoint of progression-free survival. Read More >> Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
GSK to withdraw Blenrep’s U.S. marketing authorization after FDA request By: MarketWatch November 22, 2022 at 03:42 AM EST The pharmaceutical giant said the request comes after its Dreamm-3 Phase 3 study didn't meet its primary endpoint of progression-free survival. Read More >>